Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

What was your first-ever favorite song? Who was there to listen to it and maybe even sing along with you? By Shannon Doyne If you could have a perfect weekend, how would you spend it? Where would ...

What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

In a mesmerising blend of art and mathematics, a research student from University College London (UCL) has recently gained widespread attention for creating intricate images solely through ...

“The vast majority of writing tablets offer cloud sync, but if you need access to a more specific form of file sharing, you should double-check that a tablet supports it before making the leap.

Get the Real Story Behind Every Major Earnings Report RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

The new year is here, and the race for top jobs is already heating up. According to a recent survey, Monday, January 13, was the most popular day of the year to submit resumes nationwide.

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

Following the December 2024 release of Phase 2 results with suzetrigine in painful lumbosacral radiculopathy (LSR), a form of peripheral neuropathic pain, Vertex plans to advance suzetrigine into ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...